An HIV/VL patient’s long road to better treatment

Man sitting on a bed in a hospital

Nigatu Abebe from Ethiopia sits on a bed in the Leishmaniasis Research and Treatment Centre (LRTC) at the University of Gondar in Ethiopia. He looks very frail and has been battling against visceral leishmaniasis (VL), also known as kala-azar, and HIV for 11 years.

Combination therapy found to be more effective in treating patients with leishmaniasis and HIV

Geneva/Nairobi – 17 January 2019

The results of clinical trials conducted in Ethiopia by DNDi, in partnership with Médecins Sans Frontières, the University of Gondar, and Addis Ababa University, open the way for more effective and safer treatments for people with both HIV and visceral leishmaniasis, a group of patients who have historically suffered from poor treatment options. The results were published today in PLOS Neglected Tropical Diseases.

Mondiaal Nieuws [28 December 2018]

“Ontwikkeling onmisbaar medicijn tegen ebola geen prioriteit voor grootste farmabedrijven” – “The development of indispensable medicine for Ebola is not a priority for large pharmaceutical companies”

Click here to read the article

Nuestra Tele [23 November 2018]

“‘Medicamentos para Enfermedades Olvidadas’ celebró su primera gala anual en Nueva York” – “‘Drugs for Neglected Diseases initiative’ held it’s first annual gala in New York”

Click here to read the article